ERRγ mediates Tamoxifen resistance in novel models of invasive lobular breast cancer

One-third of all ER+ breast tumors treated with endocrine therapy fail to respond, and the remainder are likely to relapse in the future. Almost all data on endocrine resistance has been obtained in models of invasive ductal carcinoma (IDC). However, invasive lobular carcinomas (ILC) comprise up to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Riggins, Rebecca B., Lan, Jennifer P-J., Zhu, Yuelin, Klimach, Uwe, Zwart, Alan, Cavalli, Luciane R., Haddad, Bassem R., Chen, Li, Gong, Ting, Xuan, Jianhua, Ethier, Stephen P., Clarke, Robert
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2701641/
https://ncbi.nlm.nih.gov/pubmed/18974135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-2669
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares